The identification of GRPR as an important target for imaging and treatment of prostate cancers has led to the development of numerous GRPR-targeting radiotracers with the aim of improving the sensitivity for detecting prostate cancer and its distant metastases. This evidence concerns the gene GRPR and prostate carcinoma.